Senior Director, Investor Relations and Corporate Communications

Lyell Immunopharma(7 days ago)

HybridFull TimeDirector$240,000 - $280,000Investor Relations

About this role

Senior Director, Investor Relations and Communications at Lyell provides senior leadership for investor-facing communications at a clinical-stage biotechnology company developing next-generation CAR T-cell therapies. The role focuses on shaping external perception of Lyell’s scientific and clinical progress and aligning corporate messaging with broader financial and industry audiences. It sits at the intersection of science, corporate strategy, and investor engagement to support the company’s growth and brand.

View Original Listing

Required Skills

Investor Relations
Corporate Communications
Media Relations
Crisis Communications
Financial Communications
Executive Presence
Stakeholder Management
Strategic Planning
Message Development
Public Speaking

Qualifications

Bachelor’s Degree in Scientific Discipline
Master’s Degree (Preferred)

About Lyell Immunopharma

lyell.com

Lyell is a fully integrated biopharmaceutical company developing next‑generation T‑cell reprogramming technologies to create durable CAR T‑cell therapies for hematologic malignancies and solid tumors. Their platform-driven approach spans discovery through clinical development, with active programs and trials such as the PiNACLE study for aggressive B‑cell non‑Hodgkin lymphoma and the recently acquired GCC‑targeted candidate LYL273. Lyell is patient‑focused, aiming to improve outcomes for cancers with significant unmet medical need.